Epilepsy and attention deficit hyperactivity disorder:Is methylphenidate safe and effective? [PDF]
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis of epilepsy and attention deficit hyperactivity disorder (ADHD).Study design: Thirty children, aged 6.4 to 16.4 years, with epilepsy and ADHD were studied ...
Manor, O +4 more
core
Background Previous meta-analyses suggested methylphenidate may be effective for cancer-related fatigue. Trial design Phase III, parallel-group, randomised, double-blind, placebo-controlled trial.
Patrick Stone +6 more
doaj +1 more source
Aim: To compare long-term safety and efficacy outcomes of centanafadine versus lisdexamfetamine dimesylate (lisdexamfetamine), methylphenidate hydrochloride (methylphenidate) and atomoxetine hydrochloride (atomoxetine), respectively, in adults with ...
Jeff Schein +7 more
doaj +1 more source
Methylphenidate and physical activity for cancer-related fatigue in immunotherapy patients: Response to letter to the editor. [PDF]
Yennurajalingam S, Bruera E.
europepmc +1 more source
Electrocardiographic effects of methylphenidate overdose [PDF]
Objectives. Stimulants used in the management of attention-deficit hyperactivity disorder have been associated with an increased risk of sudden cardiac death. One mechanism could involve drug-induced repolarization delay, reflected as prolongation of the
Thomas SHL +3 more
core
Investigation of the Effects of Methylphenidate on Hemodynamic Parameters in Children With ADHD. [PDF]
Jaicks CCD, Yıldırım SV.
europepmc +1 more source
Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients. [PDF]
Liu TH +5 more
europepmc +1 more source
Prescription stimulant consumption in the United States compared with 35 other countries. [PDF]
Bachhuber MA, Jordan AE, Piper BJ.
europepmc +1 more source
Methodological considerations in the combined methylphenidate and physical activity trial for cancer-related fatigue in immunotherapy patients. [PDF]
Sona D +3 more
europepmc +1 more source
Stimulant Medications and Bone Health. [PDF]
Swanson CM, Wolfe JH, Calarge CA.
europepmc +1 more source

